Immune response to strep pneumonia in older adults
Part of Infections clinical trials.
This study looks at how the immune system in the nose and throat reacts to Streptococcus pneumoniae bacteria and viruses in adults aged 60-85. It may help researchers find better ways to prevent or treat pneumonia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 85 years old.
- You can give consent to participate (or a legal representative can do this for you).
- You have pneumonia from Strep pneumoniae (confirmed by a test), or
- You have a viral respiratory infection (like flu or RSV), or
- You are healthy with no signs of infection or cough in the past month.
- You do not have a weakened immune system and have not used inhaled or nasal steroids in the last month.
- You are not on long-term antibiotics or on a breathing machine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body's inflammatory response (immune system markers) differs between older adults who have a current respiratory virus infection and those who don't. Researchers will measure these markers to better understand how the body fights these common infections.
This study examines how the body's natural defense system (specifically a type of immune protein) responds to common respiratory viruses like flu and cold in older adults. Researchers will analyze nasal samples that are already being collected as part of routine care to better understand why older people sometimes have different immune responses to these infections.
This study is looking at how age affects the immune system's response to a pneumococcal vaccine. Researchers want to compare younger and older adults to see if immune cells change with age.
This study looks at how acute respiratory infections (like the flu, COVID-19, or RSV) affect older adults' daily functioning. If you are 60+ and in the hospital with one of these viruses, your participation would help doctors understand the lasting impact on independence and health.
This study looks at viral respiratory infections in people over 60 who are hospitalized. Researchers will collect and test a breathing sample (a simple nasal or throat swab) to understand which viruses cause infections in older adults and how to better treat them.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
Hear when a new Pneumococcal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.